Maxence Bourgoin
Nice, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Dual targeting of GPX4 and TXNRD1 triggers eradication of AML cells through induction of apoptosis and ferroptosis.
Journal: Experimental hematology & oncology
Published: July 09, 2025
Dasatinib overcomes AML cells resistant to BCL2 inhibition by degrading MCL1.
Journal: British journal of haematology
Published: December 21, 2024
VEXAS, Chediak-Higashi syndrome and Danon disease: myeloid cell endo-lysosomal pathway dysfunction as a common denominator?
Journal: Cellular & molecular biology letters
Published: December 07, 2024
Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001.
Journal: Journal of experimental & clinical cancer research : CR
Published: November 13, 2023
The generation, activation, and polarization of monocyte-derived macrophages in human malignancies.
Journal: Frontiers in immunology
Published: March 02, 2023
Ultrasound-assisted one-pot three-component synthesis of new isoxazolines bearing sulfonamides and their evaluation against hematological malignancies.
Journal: Ultrasonics sonochemistry
Published: November 13, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026